Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
dc.creator | Almeida, Deepak | |
dc.creator | Ioerger, Thomas | |
dc.creator | Tyagi, Sandeep | |
dc.creator | Li, Si-Yang | |
dc.creator | Mdluli, Khisimuzi | |
dc.creator | Andries, Koen | |
dc.creator | Grosset, Jacques | |
dc.creator | Sacchettini, Jim | |
dc.creator | Nuermberger, Eric | |
dc.date.accessioned | 2019-10-10T16:44:05Z | |
dc.date.available | 2019-10-10T16:44:05Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 0066-4804 | |
dc.identifier.issn | 1098-6596 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/182383 | |
dc.format.extent | 1 | en |
dc.publisher | Antimicrobial Agents and Chemotherapy | |
dc.relation.ispartof | 1foldr Import 2019-10-08 Batch 9 | en |
dc.relation.uri | 10.1128/AAC.00753-16 | en |
dc.title | Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis | en |